Summer 2020 Health Care Business Roundtable: Navigating a Brave New World
On June 23, Brownstein’s Health Care industry group convened a roundtable of health care professionals and experts to discuss the health care business climate during and post COVID-19. The discussion includes trends across different health care sectors, an update from Brownstein’s Washington, D.C. team, False Claims Act issues associated with COVID-19 economic stimulus monies, the business and deal making environment and risks specific the health care industry, antitrust issues that could arise, as well as updates on the current state of the industry from medical professionals.
Panelists:
Moderator: Mike King, shareholder at Brownstein Hyatt Farber Schreck
Erin Eiselein, shareholder at Brownstein Hyatt Farber Schreck
Emily Felder, senior policy advisor and counsel at Brownstein Hyatt Farber Schreck
Alex Geier, senior health care banker at GLC Advisors & Co.
Jason Ficken, founding partner at Quadriga Partners
Allen Grunes, shareholder at Brownstein Hyatt Farber Schreck
Dr. Elizabeth Hawk, faculty at Stanford School of Medicine and president at Ampersand Intelligence
Dr. Robert Bray, founder and director of DISC
Recent Insights
Read MoreColorado Redevelopment Projects Face Impact Fee Exposure: Lessons from Carroll Partners
Podcast | May 11, 2026Section by Section the Trump Administration Rebuilds its Tariff Regime
Client Alert | May 11, 2026Section 122 Case Raises Prospect of Additional Tariff Refund
Client Alert | May 08, 2026China Invokes “Blocking Statute” Framework Ahead of Trump–Xi Summit
Client Alert | May 07, 2026Denver Amends Zoning Code to Possibly Save Thousands of Housing Units with SDP Extension
Client Alert | May 05, 2026FinCEN Proposes Sweeping AML/CFT Reforms: What Casinos Need to Know
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.